Skip to content

The effect of forward arm extension on gait initiation in patients with Parkinson*s disease

The effect of forward arm extension on gait initiation in patients with Parkinson*s disease - Arm extension and gait in PD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44386
Enrollment
23
Registered
2017-08-29
Start date
2017-11-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Forward arm extension at gait initiation
arm extension
gait
Parkinson's disease

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Healthy individuals: - Perceived healthy - Age >= 18 years - Written informed consent PD Patients: - able to walk (Hoehn & Yahr scale: Stage 2-3) - trouble initiating gait (as reported in the medical file) - PD diagnosis according to the UK Parkinson*s Disease Society Brain Bank criteria (A.J. Hughes, 1992) - Age

Exclusion criteria

Exclusion criteria: All participants - (other) neurological or motor disorder (for patients: other than PD) - Use of medication influencing movement (for patients: other than for PD)

Design outcomes

Primary

MeasureTime frame
gait velocity over the initial two meters and full six meters of walking after starting as determined using (i) a stopwatch and distance markers or (ii) IMU signals, comparing gait initiation with and without forward arm extension.

Secondary

MeasureTime frame
left and right step length as derived from IMU signals, compared between gait initiation with and without arm extension. Correlation between the primary and secondary outcome parameters and the MDS-UPDRS (Part III) motor score and item gait (3.10), in particular. Correlation between the primary study parameters and subjective assessment of changes in gait performance.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)